Results 251 to 260 of about 3,307,905 (304)

Natural carrier systems in cancer vaccines and immunotherapy. [PDF]

Hum Vaccin Immunother
Owliaee I, Shoushtari M, Karimi Z, Shojaeian A.   +3 more
europepmc   +1 more source

mRNA-Based Personalized Cancer Vaccines: Opportunities, Challenges and Outcomes. [PDF]

Acta Naturae
Ibragimova AA, Fedorov AA, Kirilenko KM, Choynzonov EL, Denisov EV, Patysheva MR.   +5 more
europepmc   +1 more source

Cancer Vaccines: Molecular Mechanisms, Clinical Progress, and Combination Immunotherapies with a Focus on Hepatocellular Carcinoma. [PDF]

Curr Issues Mol Biol
Alrumaihi F, Alromaihi RA, Kumar V, Anwar S.   +3 more
europepmc   +1 more source

Advances in Cancer Vaccines for Digestive System Cancers: A Systematic Analysis of Clinical Trials. [PDF]

Cancer Manag Res
Li J, Wang P, Wang P.
europepmc   +1 more source

Rewiring Dendritic Cell Immunity: The β-Catenin-TIM-3 Axis as a Target to Improve DC Cancer Vaccines. [PDF]

Cancers (Basel)
Fu C, Ma T, Zhou L, Mi QS, Jiang A.
europepmc   +1 more source

Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines

Zitvogel L, Carrier A, Manghi P, Silva CAC, Lahmar I, Birebent R, Suissa D, Laheurte C, Schreibelt G, Lemant L, FAHRNER J, de Sousa E, Berthier F, Villemonteix J, Chevalier M, Piccinno G, Hocquet D, Lebhar I, Maeurer M, Caillat-Zucman S, Kroemer G, Derosa L, Launay O, Golden E, Bol K, De Vries IJM, Adotévi O, Segata N, Formenti S, Kobold S, Pieper D, Vital M, Santos-Peral A, Zaucha M, García-Bengoa M, Thorn-Seshold J, Stirling H, Rothenfusser S, Iebba V, Almonte A, Ajami N, White M, Sahasrabhojane P, Hoballah Y, Losh J, DePinho C, Dondossola E, Wargo J.   +47 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cancer vaccines

Molecular Medicine Today, 1997
A better understanding of immune recognition of cells has led to identification of potential new targets on tumor cells. Noticeable successes in melanoma have been immunization with the GM2 ganglioside vaccine, and the identification of novel antigens such as MAGE, BAGE and GAGE recognized by T cells cloned from cancer patients with regressing disease.
T F, Greten, E M, Jaffee
  +8 more sources

Cancer vaccines

Seminars in Oncology Nursing, 2003
To provide a review of cancer vaccines, how they work, and the current state of the science underlying these treatments.Research studies, review articles, book chapters, personal communications.Vaccines have been studied in a variety of malignancies; however, melanoma has provided the best tumor model for vaccination.
Paula M, Muehlbauer, Douglas J, Schwartzentruber   +1 more
openaire   +4 more sources

Cancer vaccines: the next immunotherapy frontier

Nature Cancer, 2022
Brody and colleagues discuss the current status and potential of cancer vaccines, highlighting challenges and opportunities to advance promising candidates to the clinic.
Joshua D Brody, Ignacio Melero, Gabrielle Lubitz   +2 more
exaly   +2 more sources

CANCER VACCINES

Hematology/Oncology Clinics of North America, 2001
Attempts to generate an anticancer immune response in vivo in patients with cancer have taken several forms. Although to date there have been relatively few published studies describing the effects of the approach in hematologic malignancy, that circumstance is expected to change rapidly during the next few years. In solid tumors, it is not known which,
R F, Rousseau, C, Hirschmann-Jax, S, Takahashi, M K, Brenner   +3 more
openaire   +4 more sources